CD82 and prostate carcinoma: Since CD82 is located through the cell membrane and most of its functions resorted to the tetraspanin-enriched membrane microdomains (TEM) [15], we focused on the proteolytic modification to unveil the function of CD82 on posttranslational regulation of E-cadherin, which may improve our understanding of the metastatic suppressor role of CD82 and get much more details on the metastasis progress of prostate cancer.